| Patents for C07C 317 - Sulfones; Sulfoxides (15,874) |
|---|
| 05/12/2005 | WO2005042471A1 Novel nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic agents |
| 05/12/2005 | WO2005042464A1 Androgen receptor modulators |
| 05/12/2005 | WO2004092145A8 Alpha substituted carboxylic acid as ppar modulators |
| 05/12/2005 | WO2004048321A8 Phenylsulfoxide and phenylsulfone derivatives |
| 05/12/2005 | WO2004048318A8 Improved process for the preparation of 1,3-substituted indenes |
| 05/12/2005 | US20050101798 C2-substituted idan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals |
| 05/12/2005 | US20050101784 Chlorinating a 2-alkyl-6-aminobenzoxazole in an ethyl acetate solvent to form a 2-alkyl-6-amino-7-chlorobenzoxazole in which the 2-alkyl group is unbranched at the alpha carbon, for preparing a 6-chloro-2,5-dicarbonamido phenol compound |
| 05/12/2005 | US20050101528 Substituted (e)-styryl benzylsulfones for treating proliferative disorders |
| 05/12/2005 | CA2544335A1 Novel nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic agents |
| 05/12/2005 | CA2543345A1 Androgen receptor modulators |
| 05/12/2005 | CA2543326A1 Improved process for preparing benzhydrylthioacetamide |
| 05/12/2005 | CA2542970A1 Prodrugs of diaryl-2-(5h)-furanone cyclooxygenase-2 inhibitors |
| 05/12/2005 | CA2539446A1 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 05/11/2005 | CN1615295A Compounds for treatment of inflammation, diabetes and related disorders |
| 05/10/2005 | US6891066 For therapy of cancer, restenosis, psoriasis, autoimmune disease, atherosclerosis, osteoarthritis, rheumatoid arthritis, heart failure, chronic pain, and neuropathic pain |
| 05/10/2005 | US6890956 Cyclohexyl sulphones as gamma-secretase inhibitors |
| 05/10/2005 | US6890937 Inhibiting the activity of one or more of MMP-2, MMP-9 and MMP-13, while exhibiting substantially less inhibitory activity against MMP-1 |
| 05/10/2005 | CA2303801C Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists |
| 05/06/2005 | WO2005040127A1 Novel compounds as agonist for ppar gamma and ppar alpha, method for preparation of the same, and pharmaceutical composition containing the same |
| 05/06/2005 | WO2005040095A1 Inhibitors of dipeptidyl peptidase iv |
| 05/06/2005 | WO2004002939A3 Aminoalcohol derivatives |
| 05/05/2005 | US20050096357 Antibiotics; therapy for infections which is caused by drug-resistant Streptococcus, or bacteria infections |
| 05/05/2005 | US20050096222 For use in recording materials using a color developing dye, such as thermal sensitive recording material and pressure sensitive copying material, storage stability |
| 05/04/2005 | EP1527045A1 Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors |
| 05/04/2005 | CN1612729A 2-aryl-propionic acid and medicine composition containing same |
| 05/04/2005 | CN1612057A Organophotoreceptor with charge transport material having fluorenone hydrazone groups |
| 05/03/2005 | US6887877 Viricide for hepatitis virus |
| 04/28/2005 | WO2005037777A1 Process for producing bicalutamide and method of purifying intermediate therefor |
| 04/28/2005 | WO2005037763A1 Phenoxyether derivatives as ppar modulators |
| 04/28/2005 | WO2005037269A1 Novel piperidine derivative |
| 04/28/2005 | WO2005037257A2 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | WO2005037206A2 Anti-cancer compounds and methods of use thereof |
| 04/28/2005 | WO2005037205A2 Haloacetamide and azide substituted compounds and methods of use thereof |
| 04/28/2005 | WO2004014844A3 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 04/28/2005 | US20050090682 Novel process for preparing rac-bicalutamide and its intermediates |
| 04/28/2005 | US20050090669 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists |
| 04/28/2005 | US20050090543 Method for the preparation of tetrahydrobenzothiepines |
| 04/28/2005 | CA2542723A1 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | CA2541751A1 Phenoxyether derivatives as ppar modulators |
| 04/27/2005 | EP1525186A1 Inhibitors of hcv ns5b polymerase |
| 04/27/2005 | EP1525183A1 Inhibitors of hcv ns5b polymerase |
| 04/27/2005 | EP0968181B1 Perfluorynated sulphone salts, and their uses as ionic conduction materials |
| 04/27/2005 | CN1610659A Carboxylic acid derivative |
| 04/27/2005 | CN1610547A N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor |
| 04/26/2005 | US6884907 Containing carboxylic acid groups; diagnosis; prophylaxis |
| 04/26/2005 | CA2244134C Diphenyl stilbenes as prodrugs to cox-2 inhibitors |
| 04/26/2005 | CA2131182C Method for making intermediates useful in synthesis of retroviral protease inhibitors |
| 04/21/2005 | WO2005035487A1 Process for purifying mesotrione |
| 04/21/2005 | WO2005035486A1 2-cyanobenzenesulfonamides for combating animal pests |
| 04/21/2005 | WO2005034960A1 Treatment of diseases associated with the egr-1 enhancer element |
| 04/21/2005 | WO2005018529A3 Phenoxiacetic acid derivatives |
| 04/21/2005 | WO2004062601A3 Antibacterial agents |
| 04/21/2005 | US20050085541 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 04/21/2005 | US20050085538 Administering strylacrylonitrile compound; antiproliferative agents; anticancer agents |
| 04/21/2005 | US20050084763 low melting electrolyte comprising salts where the anionic charge is delocalized, mixed with metallic salts, polar polymers and/or aprotic solvents |
| 04/21/2005 | US20050082509 Fluorosulfone compounds |
| 04/21/2005 | CA2541590A1 Treatment of diseases associated with the egr-1 enhancer element |
| 04/21/2005 | CA2539563A1 2-cyanobenzenesulfonamides for combating animal pests |
| 04/21/2005 | CA2537986A1 Process for purifying mesotrione |
| 04/20/2005 | EP1196417B1 1,2,3,4,5,6-HEXAHYDROAZEPINO 4,5-b]INDOLES CONTAINING ARYLSULFONES AT THE 9-POSITION |
| 04/20/2005 | EP1165495B1 Resorcinol derivatives |
| 04/20/2005 | CN1197864C Process for preparation of pyrazolo pyridazine derivatives |
| 04/19/2005 | US6881735 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/14/2005 | US20050080256 Oxidation of the correspinding sulfide compound in presence of complex, base and solvent |
| 04/13/2005 | EP1522899A2 Organophotorecpetor with charge transport material having fluorenone hydrazone groups |
| 04/12/2005 | US6878823 Substituted and unsubstitued 9-arylsulfone- 1,2,3,4,5,6-hexahydroazepino (4,5-b) indoles are useful in treatment of depression, obesity and other central nervous system disorders |
| 04/12/2005 | US6878750 Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents |
| 04/12/2005 | US6878743 Controlling apoptosis; central nervous system disorders |
| 04/12/2005 | US6878720 VEGF receptor tyrosine kinase inhibitors |
| 04/07/2005 | WO2005030746A1 Calcilytic compounds |
| 04/07/2005 | WO2005030736A1 Derivatives of 1,3-diones having a herbicidal activity |
| 04/07/2005 | WO2005030699A1 Substituted benzanilide compound and pest control agent |
| 04/07/2005 | WO2005014533A3 Aryl and heteroaryl compounds, compositions, and methods of use |
| 04/07/2005 | WO2004110364A9 Thiotungstate analogues and uses thereof |
| 04/07/2005 | WO2004075841A3 Process for preparing benzhydrylthioacetamide |
| 04/07/2005 | US20050075512 Diamine derivatives, process for producing the same, and bactericide containing the same as active ingredient |
| 04/07/2005 | US20050075394 Phenethanolamine derivatives for treatment of respiratory diseases |
| 04/07/2005 | US20050075377 Compounds for elevating plasma lipid levels with prodrugs for humans and other mammals |
| 04/07/2005 | US20050075374 Sulfonyl aryl or heteroaryl hydroxamic acid compounds |
| 04/07/2005 | US20050075332 Tricyclic compounds with antiviral activity |
| 04/07/2005 | US20050074668 Perfluorinated amide salts and their uses as ionic conducting materials |
| 04/07/2005 | CA2539744A1 Derivatives of 1,3-diones having a herbicidal activity |
| 04/06/2005 | EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators |
| 04/06/2005 | EP0960096B1 Substituted beta-thiocarboxylic acids |
| 04/06/2005 | EP0748219B1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/06/2005 | CN1604891A Improved methods of ortho alkylation |
| 04/06/2005 | CN1603964A Organophotoreceptor with charge transport material having bis(9-fluorenone) azine groups |
| 04/06/2005 | CN1195738C 2'-substd. 1, 1'-biphenyl-2-carbonamides, method for production thereof, use thereof as medicament and pharmaceutical preparation contg. said compounds |
| 04/05/2005 | US6875893 Preparations of a sulfinyl acetamide |
| 04/05/2005 | US6875780 Compounds that modulate PPAR activity and methods for their preparation |
| 04/05/2005 | US6875760 Glucagon antagonists/inverse agonists |
| 04/05/2005 | CA1341478C Therapeutic methods using catalytic antibodies |
| 03/31/2005 | WO2005028429A2 Haloalkyl containing compounds as cysteine protease inhibitors |
| 03/31/2005 | WO2005028428A1 Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation |
| 03/31/2005 | WO2005028426A1 Novel 4-phenylamino-benzaldoxime derivative and use thereof as mek inhibitor |
| 03/31/2005 | WO2004073606A3 Sulfonamide derivatives as ppar modulators |
| 03/31/2005 | US20050070741 Reacting trifluoroalkylsulfinic acid with metal compound; heating, refluxing in presence of Lewis acid catalyst |
| 03/31/2005 | US20050070485 Phenylalanine derivatives |
| 03/31/2005 | US20050069795 Organophotoreceptor with charge transport material having bis(9-fluorenone) azine groups |
| 03/31/2005 | US20050069794 Organophotoreceptor with charge transport material having fluorenone hydrazone groups |